Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The annual risk of transformation of non-hypervascular magnetic resonance (MR) hepatobiliary phase imaging (HBPI) hypointense nodules into hypervascular hepatocellular carcinomas (HCCs) was evaluated. Methods: Cirrhotic patients with non-hypervascular HBPI hypointense nodules were retrospectively analyzed if they were diagnosed as HCC and MR followed up longer than 1 year during the period from January 2010 to October 2016 with regular intervals of 3 to 6 months. Risk factors for transformation into hypervascular HCCs were analyzed using the Cox proportional hazard model. Results: Among the 103 non-hypervascular HBPI hypointense nodules meeting the inclusion criteria, transformation into hypervascular HCCs occurred in 44 tumors (42.7%). The median follow-up period was 24 months. Multivariate analysis revealed that hyperintensity on T2-weighted images (T2WI) and diffusion-weighted images (DWI) were the two independent predictors of transformation into hypervascular HCCs (p=0.036 and p=0.041, respectively). Most tumors with hyperintensity on T2WI or DWI on the initial or follow-up MR were transformed into hypervascular HCCs within the first year. Among the 22 nodules (21.3%) showing a new change in dynamic phases during follow-up, 14 nodules (13.6%) showed malignant transformations. Conclusions: The transformation rates of HBPI hypointense nodules into hypervascular HCCs could be predicted according to the initial or serial MRI findings.
Abstract
Background/Aims: The annual risk of transformation of non-hypervascular magnetic resonance (MR) hepatobiliary phase imaging (HBPI) hypointense nodules into hypervascular hepatocellular carcinomas (HCCs) was evaluated. Methods: Cirrhotic patients with non-hypervascular HBPI hypointense nodules were retrospectively analyzed if they were diagnosed as HCC and MR followed up longer than 1 year during the period from January 2010 to October 2016 with regular intervals of 3 to 6 months. Risk factors for transformation into hypervascular HCCs were analyzed using the Cox proportional hazard model. Results: Among the 103 non-hypervascular HBPI hypointense nodules meeting the inclusion criteria, transformation into hypervascular HCCs occurred in 44 tumors (42.7%). The median follow-up period was 24 months. Multivariate analysis revealed that hyperintensity on T2-weighted images (T2WI) and diffusion-weighted images (DWI) were the two independent predictors of transformation into hypervascular HCCs (p=0.036 and p=0.041, respectively). Most tumors with hyperintensity on T2WI or DWI on the initial or follow-up MR were transformed into hypervascular HCCs within the first year. Among the 22 nodules (21.3%) showing a new change in dynamic phases during follow-up, 14 nodules (13.6%) showed malignant transformations. Conclusions: The transformation rates of HBPI hypointense nodules into hypervascular HCCs could be predicted according to the initial or serial MRI findings.
참고문헌 (21)
- Takayama T, "Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma", Lancet, 336, pp.1150~1153 (1990)[DOI]
- Kitao A, "Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation", Radiology, 252, pp.605~614 (2009)[DOI]
- El-Serag HB, "Rising incidence of hepatocellular carcinoma in the United States", N Engl J Med, 340, pp.745~750 (1999)[DOI]
- Choi BI, "Diagnosing borderline hepatic nodules in hepatocarcinogenesis: imaging performance", AJR Am J Roentgenol, 205, pp.10~21 (2015)[DOI]
- Nakashima O, "Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins", Hepatology, 22, pp.101~105 (1995)
- Kim SH, "Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results", Eur Radiol, 18, pp.814~821 (2008)[DOI]
- Lee DH, "Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation", J Hepatol, 62, pp.1122~1130 (2015)
- Inoue T, "Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT", J Gastroenterol, 47, pp.1036~1047 (2012)[DOI]
- Kobayashi S, "Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI", Eur J Radiol, 81, pp.3839~3845 (2012)[DOI]
- Kitao A, "The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging", Eur Radiol, 21, pp.2056~2066 (2011)[DOI]
- Hyodo T, "Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma", Radiology, 266, pp.480~490 (2013)[DOI]
- Kim YK, "Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC", Radiology, 265, pp.104~114 (2012)[DOI]
- Kumada T, "Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI", AJR Am J Roentgenol, 197, pp.58~63 (2011)[DOI]
- Forner A, "Hepatocellular carcinoma", Lancet, 379, pp.1245~1255 (2012)[DOI]
- Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)[DOI]
- An C, "Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma", Eur Radiol, 23, pp.924~930 (2013)[DOI]
- Winters SD, "Value of subtraction MRI in assessing treatment response following image-guided loco-regional therapies for hepatocellular carcinoma", Clin Radiol, 67, pp.649~655 (2012)[DOI]
- Toyoda H, "Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy", J Hepatol, 58, pp.1174~1180 (2013)[DOI]
- Cho YK, "Radiofrequency ablation of high-grade dysplastic nodules", Hepatology, 54, pp.2005~2011 (2011)[DOI]
- Midorikawa Y, "Marginal survival benefit in the treatment of early hepatocellular carcinoma", J Hepatol, 58, pp.306~311 (2013)[DOI]
- Chang KJ, "3.0-T MR imaging of the abdomen: comparison with 1.5 T", Radiographics, 28, pp.1983~1998 (2008)[DOI]